Abstract:Bradley Beauvais, 1 Zachary Whitaker, 2 Forest Kim, 2 Benjamin Anderson 3 1 Texas State University, San Marcos, TX, USA; 2 Baylor University, Waco, TX, USA; 3 Colorado Hospital Association, Greenwood Village, CO, USA Correspondence: Bradley Beauvais, Tel +210 627-1078, Email Introduction: Hospital readmissions have been associated with adverse outcomes and elevated financial costs to patients, families, and hospitals across the United States. Historically, nearly 20% of all Medicare discharges had a readmission within 30 days. In an effort to address this issue, the Affordable Care Act (ACA) established the Hospital Readmission Reduction Program (HRRP) in 2012 to positively influence readmissions associated with acute myocardial infarction, chronic obstructive pulmonary disease, heart failure, pneumonia, coronary artery bypass graft surgery, and total hip and/or knee arthroplasty. However, as recently as 2018, there were still 3.8 million 30-day all-cause adult hospital readmissions, with a 14% readmission rate and an average readmission cost of $15,200. The ACA also produced the Hospital Value-Based Purchasing (HVBP) program with the stated intent to (1) reduce mortality and complications, (2) reduce healthcare-associated infections, (3) increase patient safety, (4) improve the patient experience, and (5) increase efficiency and reduce costs. Given the costs and quality implications of an average readmission, it is logical to believe that HVBP eligible hospitals are simultaneously seeking to meet the goals of both programs. However, to date, no studies have examined if that is the case. Thus, in this study, we seek to determine if HVBP eligible hospitals are associated with a reduction in the core set of HRRP readmission rates better than the facilities that are not eligible for the HVBP program. Methods: Hospital-level data from calendar year 2019 for 3,276 short-term acute care hospitals in the United States were evaluated using multivariate regression analysis to examine the readmission rate performance between 2,719 HVBP eligible hospitals and 557 ineligible hospitals. Results: Our six separate multivariable linear regressions revealed a statistically significant and positive association between HVBP participation and readmission rates after controlling for numerous organizational, clinical complexity, and environmental factors. In each case, the magnitude of the positive directional association is moderate, ranging from and increase of +0.19% (pneumonia readmissions) to as high as +0.37% (all cause readmissions) for HVBP eligible hospitals. When considered in the context of the average number of discharges in our data set (x- = 9570), a third of a percent increase from the average 15.56% all cause readmissions to 16.08% in HVBP eligible hospitals equates to 50 additional readmissions annually (9570 × 15.56% = 1,489 vs 9570 × 16.08% = 1,539). At an average cost of 760,000. Discussion: The fact that there is a positive association between HVBP participating hospitals and readmissions at all, and that the same effect appears to be persistent across all dependent measures is concerning. One would logically expect hospitals that are focused on quality-based care to thoroughly care for individuals in order for them to not be readmitted to the hospital. The results provided do not necessarily prove that either program is not working. But they also do not confirm that the HVBP and HRRP programs are working together and accomplishing what they were originally designed to do: improve patient care and lower health-care costs. Keywords: hospitals, value-based care, HVBP, readmissions, HRRP In the United States, health care is a $4 trillion industry (2020) and currently accounts for 17.7% of US Gross Domestic Product (GDP), and nearly a third of this cost (32.8%) is directly attributable to hospital care. 5 The trajectory of health-care cost inflation shows little sign of slowing down as the health-care share of GDP is expected to rise to 19.7% by 2028. 6 A significant portion of the expense incurred within the US healthcare system can be attributed to hospital readmission. 1,2 In addition, over $52.4 billion is spent annually to care for patients that were readmitted to the hospital within 30 days for a previously treated condition. 7,8 As recently as 2018, there were 3.8 million 30-day all-cause adult hospital readmissions, with a 14% readmission rate and an average readmission cost of $15,200. 3 The 111th United States Congress and President Barack Obama sought to address these issues wit -Abstract Truncated-

Medicare's Hospital Readmission Reduction Program reduced fall-related health care use: An unexpected benefit?

Accounting for the Growth of Observation Stays in the Assessment of Medicare's Hospital Readmissions Reduction Program

Medicare's hospital readmissions reduction program and the rise in observation stays

Trends in 30-Day Readmission Rates for Medicare and Non-Medicare Patients in the Era of the Affordable Care Act

Regression to the Mean in the Medicare Hospital Readmissions Reduction Program

Readmissions performance and penalty experience of safety-net hospitals under Medicare’s Hospital Readmissions Reduction Program

Frontloaded Home Health Physical Therapy Reduces Hospital Readmissions among Medicare Fee-for-Service Beneficiaries

The Long-Term Effect of Financial Penalties on 30-Day Hospital Readmission Rates

Hospitals serving nursing home residents disproportionately penalized under hospital readmissions reduction program

Impact of time from discharge to readmission on outcomes: an observational study from the US National Readmission Database

1564 INCIDENCE AND HEALTHCARE COST OF FALL-RELATED READMISSIONS AFTER DISCHARGE AMONG OLDER PATIENTS

What is the impact of a clinically related readmission measure on the assessment of hospital performance?

Efficacy of Remote Health Monitoring in Reducing Hospital Readmissions Among High-Risk Postdischarge Patients: Prospective Cohort Study

National Patterns of Remote Patient Monitoring Service Availability at US Hospitals and their Readmission Performance for Cardiovascular Conditions

Impact of Hospital Readmissions Reduction Program Policy on 30-Day and 90-Day Readmissions in Patients With Acute Myocardial Infarction: A 10-Year Trend From the National Readmissions Database

Trends in 30- and 90-Day Readmission Rates for Heart Failure

Predicting Risk Factors for 30-Day Readmissions Following Discharge From Post-Acute Care

Is the Hospital Value-Based Purchasing Program Associated with Reduced Hospital Readmissions?

Strategies to prevent hospital readmission and death in patients with chronic heart failure, chronic obstructive pulmonary disease, and chronic kidney disease: A systematic review and meta-analysis

Evaluation of Pharmacy Resident-Driven Medication Reconciliation on Patients at High Risk of Hospital Readmission